Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab175883 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Ixekizumab (anti-CTLA-8)
- Antibody type
- Recombinant
- Description
- Ixekizumab (anti-CTLA-8) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab (anti-CTLA-8) directly blocks IL-17A binding to IL-17RA (IL-17A receptor) but does not bind to other IL-17 family members. Ixekizumab (anti-CTLA-8) is used for the research of moderate-to-severe plaque psoriasis.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Ixekizumab (anti-CTLA-8) (Ab175883) - ELISA Immobilized Recombinant Human IL-17A Protein at 0.5 μg/mL can bind Ixekizumab (anti-CTLA-8) (Ab175883) with the EC₅₀ of 33.85 ng/mL.
